← All Emergent Biosolutions INC filings

Emergent Biosolutions INC Form 4 insider transactions

NYSE
EBS
Emergent Biosolutions INC
Form 4: Emergent BioSolutions Executive Jennifer Fox Reports Stock Transaction
EVP Jennifer Lynne Fox reports disposition of Emergent BioSolutions shares to cover tax obligations.
NYSE
EBS
Emergent Biosolutions INC
Form 4: Emergent BioSolutions EVP, CFO Richard Lindahl Reports Changes in Beneficial Ownership
Richard Lindahl, EVP and CFO of Emergent BioSolutions, reports the disposition of shares due to performance stock unit vesting and tax withholding.